SLXN
Financials
- Market Capitalization 2 M
- Employee 13
- Founded 2008
- CEO N/A
- Website silexion.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5047 |  SPRC SciSparc Ltd. - Ordinary Shares | 6.58 USD | -0.60% | -4.91% | -27.69% | +169.67% | 2.40 M USD | ||
| 5049 |  OGEN Oragenics Inc. Common Stock | 0.53 USD | -1.85% | 0.00% | +6.00% | -16.34% | 2.39 M USD | ||
| 5077 |  VRAX Virax Biolabs Group Limited - Ordinary Shares | 2.86 USD | -2.72% | -8.92% | -3.05% | +384.75% | 1.66 M USD | ||
| 5080 |  PPBT Purple Biotech Ltd - American Depositary Shares | 1.68 USD | +1.20% | +9.09% | +19.15% | +189.66% | 1.56 M USD |
Frequently asked questions about Silexion Therapeutics Corp Ordinary Shares
What is the Silexion Therapeutics Corp Ordinary Shares stock price today?
The current price of Silexion Therapeutics Corp Ordinary Shares (SLXN) is 0.36. Over the past 24 hours, the stock has changed by 0.00%. Follow the SLXN chart for real-time price dynamics.
What is the stock ticker of Silexion Therapeutics Corp Ordinary Shares?
Silexion Therapeutics Corp Ordinary Shares trades under the ticker SLXN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Silexion Therapeutics Corp Ordinary Shares stock going up?
SLXN has changed by -5.26% over the last week, -77.50% over the last month, and -77.64% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Silexion Therapeutics Corp Ordinary Shares?
Silexion Therapeutics Corp Ordinary Shares currently has a market capitalization of 2 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Silexion Therapeutics Corp Ordinary Shares earnings last quarter?
Last quarter, Silexion Therapeutics Corp Ordinary Shares reported earnings of 5.17 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Silexion Therapeutics Corp Ordinary Shares revenue for the last quarter?
Silexion Therapeutics Corp Ordinary Shares reported quarterly revenue of 40 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Silexion Therapeutics Corp Ordinary Shares net income for the last quarter?
Silexion Therapeutics Corp Ordinary Shares reported net income of -3.55 M for the last quarter. The previous quarter showed -2.73 M, which means net income changed by -29.93%.
How many employees does Silexion Therapeutics Corp Ordinary Shares have?
As of the latest available data, Silexion Therapeutics Corp Ordinary Shares has 13 employees. Workforce size can provide additional context about the company's scale and operations.
What is Silexion Therapeutics Corp Ordinary Shares EBITDA?
Silexion Therapeutics Corp Ordinary Shares EBITDA is -3.64 M, and its EBITDA margin is -9 092.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Silexion Therapeutics Corp Ordinary Shares stock?
You can buy Silexion Therapeutics Corp Ordinary Shares (SLXN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Silexion Therapeutics Corp Ordinary Shares stock?
Investing in Silexion Therapeutics Corp Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLXN chart and related analysis on metatrader.com as part of your research.